Literature DB >> 13130403

Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.

Connie S Price1, Suzanne Paule, Gary A Noskin, Lance R Peterson.   

Abstract

The impact of active surveillance of patients at risk for infection with vancomycin-resistant enterococci (VRE) was examined, and VRE bacteremia rates and the degree of VRE clonality in 2 similar neighboring hospitals were compared. Hospital A did not routinely screen patients for VRE rectal colonization; hospital B actively screened high-risk patients. Retrospective observations were made over the course of 6 years, beginning when initial VRE bloodstream isolates were recovered at each institution. The rate of VRE bacteremia was 2.1-fold higher at hospital A, and the majority of hospital A isolates were clonally related: 4 clones were responsible for infection in >75% of patients with VRE bacteremia, and isolates from 30% of patients were from the most common clone. The 4 most common clones at hospital B were responsible for infection in 37% of patients, and isolates from 14.5% of patients were from the most common clone. Lower VRE bacteremia rates and a more polyclonal population, representing less horizontal transmission, may result from routine screening of patients who are at risk for VRE and prompt contact isolation of colonized individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130403     DOI: 10.1086/377733

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need.

Authors:  Daniel J Diekema; Kirsty J Dodgson; Bryndis Sigurdardottir; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 2.  Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  B Lynn Johnston; Elizabeth Bryce
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

Review 3.  An Ounce of Prevention Saves Tons of Lives: Infection in Burns.

Authors:  Nishant Merchant; Karen Smith; Marc G Jeschke
Journal:  Surg Infect (Larchmt)       Date:  2015-06-02       Impact factor: 2.150

4.  Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients.

Authors:  M Schmidt-Hieber; I W Blau; S Schwartz; L Uharek; K Weist; T Eckmanns; D Jonas; H Rüden; E Thiel; C Brandt
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 5.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.

Authors:  Matthew L Faron; Nathan A Ledeboer; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

Review 6.  Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.

Authors:  Nico T Mutters; Volker Mersch-Sundermann; Reinier Mutters; Christian Brandt; Wulf Schneider-Brachert; Uwe Frank
Journal:  Dtsch Arztebl Int       Date:  2013-10-25       Impact factor: 5.594

7.  Hospital acquired vancomycin resistant enterococci in surgical intensive care patients - a prospective longitudinal study.

Authors:  Stefanie Kampmeier; Annelene Kossow; Larissa Monika Clausen; Dennis Knaack; Christian Ertmer; Antje Gottschalk; Hendrik Freise; Alexander Mellmann
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-23       Impact factor: 4.887

8.  Results of Four-Year Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection.

Authors:  Hacer Aktürk; Murat Sütçü; Ayper Somer; Serap Karaman; Manolya Acar; Ayşegül Ünüvar; Sema Anak; Zeynep Karakaş; Aslı Özdemir; Kutay Sarsar; Derya Aydın; Nuran Salman
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

9.  Weekly screening supports terminating nosocomial transmissions of vancomycin-resistant enterococci on an oncologic ward - a retrospective analysis.

Authors:  Stefanie Kampmeier; Dennis Knaack; Annelene Kossow; Stefanie Willems; Christoph Schliemann; Wolfgang E Berdel; Frank Kipp; Alexander Mellmann
Journal:  Antimicrob Resist Infect Control       Date:  2017-05-16       Impact factor: 4.887

10.  Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.

Authors:  Agnes Loo Yee Cheah; Allen C Cheng; Denis Spelman; Roger L Nation; David C M Kong; Emma S McBryde
Journal:  BMC Infect Dis       Date:  2018-10-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.